The Drugs Controller General of India will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.
Bharat Biotech said that it is disheartening to listen to some states complaining about company's intentions regarding supply of COVID vaccine Covaxin.
Modi is also likely to launch the Co-WIN (COVID Vaccine Intelligence Network) App, a digital platform created for real-time monitoring of COVID-19 vaccine delivery and distribution.
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals. The Pune-based Serum Institute of India, the world's largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, 'Covishield', for state governments and Rs 600 per dose for private hospitals.
SII executive director Suresh Jadhav on Friday alleged that the government began inoculating people from multiple age groups without taking into account the available stock of vaccines and the WHO guidelines.
Representatives from seven vaccine makers -- Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech -- will be participating in the meeting.
Adnan Abidi, Sanna Irshad Mattoo, Amit Dave and the late Danish Siddiqui, who was killed last July while on assignment covering the war in Afghanistan, won the Pulitzer Prize for Feature Photography for coverage of the coronavirus pandemic in India.
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.
Noting that India's COVID-19 vaccination will cross the landmark of 100 crore vaccine doses in a few days, Union health minister Mansukh Mandaviya said on Wednesday that the country will produce over 28 crore doses of vaccine in October as it continues to ramp up its supply.
This year, eight eminent individuals are being given Padma Bhushan and 54 are being conferred with Padma Shri awards, besides the two Padma Vibhushan recipents.
A bench of Justices L Nageswara Rao and B R Gavai said bodily autonomy and integrity are protected under Article 21 of the Constitution.
His visit to India followed a few cancelled plans since he took office in July 2019 due to the coronavirus pandemic crisis, with the two leaders holding several virtual talks and eventually meeting in person on the sidelines of the COP26 climate summit in Glasgow last November.
While Mahipal's family is blaming the death on vaccination, the authorities cited an autopsy report to say that he suffered from a cardiac disease.
Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is administered, but reaching a firm opinion on this will need more scrutiny and understanding, the Centre said.
Three big private hospital chains -- Apollo, Fortis and Max -- on Friday announced the launch of Covid-19 immunisation drive for the 18-44 age group at limited centres in the country from May 1 while the Delhi government said it will start the vaccination exercise once it receives doses from the manufacturers.
Delhi and some other states have said that they would be unable to do so due to the shortage of vaccine doses.
India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.
Serum Institute of India announced a price of Rs 400 per dose for its COVID-19 vaccine 'Covishield' for state governments and Rs 600 per dose for private hospitals.
Briefing the media in Rome, Goyal said the Leaders adopted the 'Rome Declaration' at the G20 Summit and the communique gives a very strong message under the health section with the countries agreeing that the COVID-19 immunisation is a global public good.
Serum Institute along with other vaccine producers have agreed with the government to sacrifice profits. There is no vaccine industry on the planet that has agreed to provide vaccines at such a subsidised price, he added.
'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'
Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
865 million Indian adults require vaccination.
In a letter to the prime minister, the Congress chief alleged that the new vaccine policy implies that the central government has abdicated its responsibility of providing free vaccine to all Indians between 18 and 45 years of age.
People aged 45 and above account for about 88 per cent of all COVID-19 deaths in India making them the most vulnerable section, the Union health ministry said on Wednesday, a day after the government opened up vaccinations for all those in the age bracket from April 1.
The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.
'WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin,' the global health body tweeted.
Here's a look at just some of the bigwigs who took the anti-Covid jab.
Earlier, it was reported that the judges of the apex court would get the option to choose between Covaxin or Covishield vaccines. Later, the Union health ministry, in a clarification, said the judges have not been given any such option to choose between both the vaccines, adding that it will be conducted entirely through Co-Win system.
'This will not be the last time a virus threatens our lives and our livelihoods'
A man came on a motorcycle and left the vaccines at a tea stall outside the Civil Lines police station.
Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.
Most coronavirus infections are not severe and do not need hospitalisation, the office of the Principal Scientific Adviser said on Friday, prescribing home-care tips for patients.
Prime Minister Narendra Modi said on Wednesday that international travel should be made easier through mutual recognition of vaccine certificates, amid several countries adopting different sets of rules to allow foreigners to enter their territory in the wake of the COVID-19 pandemic.
Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose.
'We really need to look seriously to see if there are any local variants.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances